Annals of Surgical Oncology Cite Track
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Steele, G. D.
Right arrow Articles by Mayer, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Steele, G. D., Jr
Right arrow Articles by Mayer, R. J.

Annals of Surgical Oncology, Vol 6, Issue 5 433-441, Copyright © 1999 by Society of Surgical Oncology


ARTICLES

Sphincter-sparing treatment for distal rectal adenocarcinoma

G. D. Steele Jr, J. E. Herndon, R. Bleday, A. Russell, A. Benson 3rd, M. Hussain, A. Burgess, J. E. Tepper and R. J. Mayer
University of Chicago, IL 60637, USA. buckley@delphi.bsd.uchicago.edu

BACKGROUND: Studies suggest that the anal sphincter can be preserved in some patients with distal rectal adenocarcinoma (DRA), but this has not been validated in any prospective multi-institutional trial. METHODS: To test the hypothesis that the anal sphincter can be preserved in some patients with DRA, the Cancer and Leukemia Group B and collaborators reviewed 177 patients who had T1/T2 adenocarcinomas < or = 4 cm in diameter, which encompassed < or = 40% of bowel wall circumference, and were < or = 10 cm from the dentate line. Of the 177 patients, 59 patients who were eligible for the study had T1 adenocarcinomas and received no further treatment; 51 eligible T2 patients received external beam irradiation (5400 cGY/30 fractions 5 days/week) and 5-fluorouracil (500 mg/m2 IV d1-3, d29-31) after local excision. RESULTS: At 48 months median follow-up, 6-year survival and failure-free survival rates of the eligible patients are 85% and 78% respectively. Three patients died of unrelated disease. Two patients were treated for second primary colorectal tumors; both remain disease free (NED). Another eight patients died of disease, four with distant recurrence only. One T1 patient is alive with distant disease. Two T1 and seven T2 patients experienced isolated local recurrences; all underwent salvage abdominoperineal resection (APR). After APR, one T1 and four of seven T2 patients were NED at the time of last visit (2-7 years). One T1 patient died of local and distant disease. Three of seven T2 patients died with distant disease. CONCLUSIONS: We conclude that sphincter preservation can be achieved with excellent cancer control without initial sacrifice of anal function in most patients. After local recurrence, salvage resection appears effective, but longer follow-up time of local and distant disease-free survival is advised before extrapolation to patients with T3 primaries.


This article has been cited by other articles:


Home page
Ann. Surg. Oncol.Home page
T. Borschitz, I. Gockel, R. Kiesslich, and T. Junginger
Oncological Outcome After Local Excision of Rectal Carcinomas
Ann. Surg. Oncol., November 1, 2008; 15(11): 3101 - 3108.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
N. Petrelli
Society of Surgical Oncology Heritage Award: Honoring Glenn D. Steele, Jr, MD, PhD
Ann. Surg. Oncol., June 1, 2008; 15(6): 1553 - 1554.
[Full Text] [PDF]


Home page
CA Cancer J ClinHome page
B. M. Wolpin, J. A. Meyerhardt, H. J. Mamon, and R. J. Mayer
Adjuvant Treatment of Colorectal Cancer
CA Cancer J Clin, May 1, 2007; 57(3): 168 - 185.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
N. N. Baxter and J. Garcia-Aguilar
Organ Preservation for Rectal Cancer
J. Clin. Oncol., March 10, 2007; 25(8): 1014 - 1020.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
D. M. Ota, H. Nelson, and ACOSOG Group Co-Chairs
Local Excision of Rectal Cancer Revisited: ACOSOG Protocol Z6041
Ann. Surg. Oncol., February 1, 2007; 14(2): 271 - 271.
[Full Text] [PDF]


Home page
Mayo Clin. Proc.Home page
S. Gill, A. W. Blackstock, and R. M. Goldberg
Colorectal Cancer
Mayo Clin. Proc., January 1, 2007; 82(1): 114 - 129.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
L. J. Kohman
Cancer and leukemia group B surgery committee.
Clin. Cancer Res., June 1, 2006; 12(11): 3622s - 3627s.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
S. Ganai, P. Kanumuri, R. S. Rao, and A. I. Alexander
Local Recurrence After Transanal Endoscopic Microsurgery for Rectal Polyps and Early Cancers
Ann. Surg. Oncol., April 1, 2006; 13(4): 547 - 556.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
R. Rengan, P. Paty, W. D. Wong, J. Guillem, M. Weiser, L. Temple, L. Saltz, and B. D. Minsky
Distal cT2N0 Rectal Cancer: Is There an Alternative to Abdominoperineal Resection?
J. Clin. Oncol., August 1, 2005; 23(22): 4905 - 4912.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
M. O. Meyers and J. E. Tepper
Rectal Cancer: Can We Throw Away the Scalpel?
Ann. Surg. Oncol., February 1, 2005; 12(2): 95 - 97.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the Society of Surgical Oncology.